New cell therapy shows promise in battle against Hard-to-Treat multiple myeloma
NCT ID NCT06413498
First seen Jun 27, 2026 · Last updated Jul 30, 2026 · Updated 4 times
Summary
This study tests a new treatment called anitocabtagene autoleucel (a type of cell therapy) against standard treatments for people with multiple myeloma that has returned or not responded to 1-3 prior therapies. About 450 participants will be randomly assigned to receive either the new cell therapy or standard care. The main goal is to see which approach better delays cancer progression and reduces signs of the disease in the bone marrow.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AOU Città della Salute e della Scienza Presidio Ospedaliero Molinette
Torino, 10126, Italy
-
Amsterdam UMC - Location vUmc
Amsterdam, 1081 HV, Netherlands
-
Banner MD Anderson Cancer Center
Gilbert, Arizona, 85234, United States
-
Baptist Cancer Center
Memphis, Tennessee, 38104, United States
-
Boston Medical Center
Boston, Massachusetts, 02118, United States
-
CHU De Montpellier - Hopital Saint Eloi
Montpellier, 34080, France
-
CHU de Lille- Hopital Claude Huriez
Lille, 59037, France
-
CHU de Rennes
Rennes, 59037, France
-
CHU de Toulouse. IUCT Oncopole
Toulouse, 31100, France
-
Centre Hospitalier Universitaire de Nantes
Nantes, 44093, France
-
Centre Hospitalier Universitaire de Poitiers
Poitiers, 86021, France
-
Charité - Universitätsmedizin Berlin
Berlin, 12203, Germany
-
City of Hope (City of Hope National Medical Center, City of Hope Medical Center)
Duarte, California, 91010, United States
-
Clinica Universidad de Navarra
Pamplona, 31008, Spain
-
Cliniques Universitaires Saint-Luc
Brussels, 1200, Belgium
-
Colorado Blood Cancer Institute
Denver, Colorado, 80218, United States
-
Complejo Asistencial Universitario de Salamanca
Salamanca, 37007, Spain
-
Corewell Health - Lemmen-Holton Cancer Pavilion
Grand Rapids, Michigan, 49503, United States
-
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, 03756, United States
-
Epworth HealthCare
Richmond, Victoria, 3121, Australia
-
Erasmus Medical Center
Rotterdam, 3015GD, Netherlands
-
Fakultni Nemocnice Ostrava
Severomoravsky KRAJ, 708 52, Czechia
-
Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, MI, 20133, Italy
-
Fred Hutchinson Cancer Center
Seattle, Washington, 98109, United States
-
Henry-Joyce Cancer Clinic
Nashville, Tennessee, 37232, United States
-
Hopital Saint Antoine
Paris, 75571, France
-
Hopital Saint Louis
Paris, 75010, France
-
Hospital Clinico Universitario Virgen de la Arrixaca
El Palmar, 30120, Spain
-
Hospital Clínic de Barcelona
Barcelona, 08036, Spain
-
Hospital Duran i Reynals
Barcelona, 08908, Spain
-
Hospital Universitari i Politecnic La Fe de Valencia
Valencia, 46026, Spain
-
Hospital Universitario 12 de Octubre
Madrid, 28041, Spain
-
Hospital Universitario Marqués de Valdecilla
Santander, 39008, Spain
-
Hospital Universitario Ramon Y Cajal
Madrid, 28034, Spain
-
Hospital Universitario Virgen del Rocio
Seville, 41013, Spain
-
Houston Methodist Hospital Cancer Center
Houston, Texas, 77030, United States
-
Huntsman Cancer Institute, University of Utah
Salt Lake City, Utah, 84112, United States
-
Hyogo Medical University Hospital
Hyōgo, 663-8501, Japan
-
Hôpital Lyon Sud
Pierre-Bénite, 69495, France
-
ICO Badalona-H.U. Germans Trias i Pujol
Badalona, 08916, Spain
-
IRCCS AOU di Bologna
Bologna, 40138, Italy
-
IU Melvin and Bren Simon Comprehensive Cancer Center
Indianapolis, Indiana, 46202, United States
-
Icahn School of Medicine at Mount Sinai
New York, New York, 10029, United States
-
Inselspital - Universitätsspital Bern
Bern, 3010, Switzerland
-
Institut Paoli Calmettes
Marseille, 13273, France
-
Instytut Hematologii i Transfuzjologii
Warsaw, 02-776, Poland
-
Japanese Red Cross Medical Center
Tokyo, 150-8935, Japan
-
Jichi Medical University Hospital
Tochigi, 329-0498, Japan
-
Juntendo University School of Medicine Juntendo Clinic
Tokyo, 113-8431, Japan
-
King's College Hospital
London, SE5 9NU, United Kingdom
-
LDS Hospital
Salt Lake City, Utah, 84143, United States
-
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health
New York, New York, 10016, United States
-
Leeds Teaching Hospitals NHS Trust, St James's University Hospital
Leeds, LS9 7TF, United Kingdom
-
Levine Cancer Institute
Charlotte, North Carolina, 28204, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Mayo Clinic
Jacksonville, Florida, 32256, United States
-
Mayo Clinic
Rochester, Minnesota, 55902, United States
-
Mayo Clinic Hospital
Gilbert, Arizona, 85234, United States
-
McGill University Health Center
Montreal, H4A 3J1, Canada
-
Medical University of Vienna
Vienna, 1090, Austria
-
Moffitt Cancer Center
Tampa, Florida, 33612, United States
-
Nagoya City University Hospital
Nagoya, 467-8602, Japan
-
New Mexico Cancer Research Alliance
Albuquerque, New Mexico, 87102, United States
-
Newcastle Hospitals NHS Foundation Trust, Freeman Hospital
Newcastle, NE7 7DN, United Kingdom
-
Norton Cancer Institute, St. Matthews Campus
Louisville, Kentucky, 40207, United States
-
Novant Health Cancer Institute Hematology- Forsyth
Winston-Salem, North Carolina, 27103, United States
-
Ochsner Clinical Foundation
New Orleans, Louisiana, 70121, United States
-
Oncology Hematology West, PC dba Nebraska Cancer Specialists - Legacy
Omaha, Nebraska, 68130, United States
-
Ordensklinikum Linz GmbH Elisabethinen, Hamatologie mit Stammzelltransplantation, Hamostaseologie und medizinische Onkologie
Linz, Austria
-
Oregon Health and Science University
Portland, Oregon, 97239, United States
-
Ospedale San Raffaele
Milan, 3302, Italy
-
Paracelsus Medizinischen Privatuniversitaet
Salzburg, A-5020, Austria
-
Policlinico Universitario Argostino Gemelli
Roma, 00168, Italy
-
QEII Health Sciences Centre
Halifax, B3H 2Y9, Canada
-
Royal Adelaide Hospital
Adelaide, South Australia, 5000, Australia
-
Royal North Shore Hospital
St Leonards, New South Wales, 2065, Australia
-
Royal Prince Alfred Hospital
Camperdown, New South Wales, NSW 2050, Australia
-
Sir Charles Gairdner Hospital
Nedlands, Western Australia, 6009, Australia
-
Southeastern Regional Medical Center, Inc. dba City of Hope Atlanta
Newnan, Georgia, 30265, United States
-
St. David's South Austin Medical Center
Austin, Texas, 78704, United States
-
St. Luke's Cancer Institute
Boise, Idaho, 83712, United States
-
Stanford Cancer Institute
Stanford, California, 94305, United States
-
Swedish Cancer Institute
Seattle, Washington, 98104, United States
-
Sylvester Comprehensive Cancer Center
Coral Gables, Florida, 33146, United States
-
TUM Klinikum, Rechts der Isar, Klinik und Poliklinik fur Innere Medizin III, Hamatologie und Onkologie
München, 80333, Germany
-
Tennessee Oncology, PLLC - Greco-Hainsworth Centers for Research
Nashville, Tennessee, 37203, United States
-
The Ottawa Hospital - General Campus
Ottawa, K1H 8L6, Canada
-
The University of Osaka Hospital
Osaka, 565-0871, Japan
-
The University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
UC San Diego Moores Cancer Center
San Diego, California, 92037, United States
-
UCLA Hematology/Oncology (Bowyer Infusion Clinic)
Santa Monica, California, 90404, United States
-
USC/Norris Comprehensive Cancer Center
Los Angeles, California, 90033, United States
-
UZ Gent
Gent Oost-Vlaanderen, 9000, Belgium
-
UZ Leuven
Flemish Brabant, 3000, Belgium
-
Universitatsklinikum Hamburg Eppendorf
Hamburg, 20246, Germany
-
Universitatsklinikum Koln, Klinik I fOr lnnere Medizin
Cologne, Germany
-
Universitatsklinikum Leipzig
Leipzig, 4103, Germany
-
Universitatsklinikum Wurzburg
Tübingen, 72076, Germany
-
University College London Hospital
London, WC1E 6JN, United Kingdom
-
University Health Network - The Princess Margaret Cancer Centre
Toronto, M5G 2M9, Canada
-
University Hospital St. Poelten, Department of Internal Medicine I
Sankt Pölten, 3100, Austria
-
University Hospital of Antwerp
Edegem, Belgium
-
University Hospital of Wales
Cardiff, CF14 4XW, United Kingdom
-
University Hospitals Bristol NHS Foundation Trust, Bristol Haematology and Oncology Centre
Bristol, BS2 8ED, United Kingdom
-
University Medical Center Groningen
Groningen, 9700 RB, Netherlands
-
University of California Davis Comprehensive Cancer Center
Sacramento, California, 95817, United States
-
University of Cincinnati Cancer Center
Cincinnati, Ohio, 45219, United States
-
University of Illinois Hospital and Health Sciences System
Chicago, Illinois, 60612, United States
-
University of Maryland Greenebaum Comprehensive Cancer Center
Baltimore, Maryland, 21201, United States
-
University of Michigan
Ann Arbor, Michigan, 48109, United States
-
University of Tennessee Medical Center
Knoxville, Tennessee, 37920, United States
-
Universitätsklinikum Essen
Essen, Germany
-
Universitätsklinikum Freiburg
Freiburg im Breisgau, 79106, Germany
-
Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wrocławiu
Wroclaw, 50-367, Poland
-
Warszawa-Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego
Warsaw, 02-097, Poland
-
Weill Cornell Medicine - New York Presbyterian Hosptial
New York, New York, 10021, United States
-
Winship Cancer Institute, Emory University
Atlanta, Georgia, 30322, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict blood cancer outcomes?
- Can a Triple-Action antibody deepen remissions in myeloma?
- Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
- Can a gentler chemo prep make stem cell transplants safer for blood cancer patients?
- Talking about the end: could guided conversations reduce futile cancer treatments?
- A guided path back to work after blood cancer: a trial tests the impact